| Metric | სს ბიოფარმი | სს ინოვას |
|---|---|---|
| Growth | ||
| Revenue | ₾10.1m₾9.7m | ₾5.0m₾1.9m |
| Revenue growth | 4.8% | 165.0% |
| Profitability | ||
| EBITDA | -₾847k-₾427k | ₾2.8m₾549k |
| EBITDA margin | -8.3%-4.4% | 56.5%29.1% |
| Net profit | -₾1.3m-₾1.1m | ₾2.7m₾378k |
| Net margin | -12.6%-11.5% | 54.8%20.0% |
| Balance sheet | ||
| Total assets | ₾19.1m₾18.5m | ₾6.3m₾4.0m |
| Total equity | ₾18.2m₾17.1m | ₾5.5m₾3.2m |
| ROE | -7.0%-6.5% | 49.8%11.7% |